ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 120925 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 120925; 2) Community: the network communities that were significantly associated with the response to NSC 120925; 3) Molecule: the relationships between components within communities and NSC 120925; 4) MDR: the compounds that were significantly associated with the NSC 120925.

NSC Compound Enrichment Correlation
NSC 724779 1-{[(1R,4S,5R,8S,12R,13R)-1,5-dimethyl-10-(trifluoromethyl)- 11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec-9- en-9-yl]methyl}-4-{[1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(tr ifluoromethyl)-1 0.0133986477026051 0.3177094
NSC 726904 Null 0.0133986477026051 0.15711098
NSC 763621 (Z)-3-((2-(4-(trifluoromethyl)phenyl)-3H-benzo[d]imidazol-5-yl)methylene)indolin-2-one 0.0133986477026051 0.25338165
NSC 129757 Null 0.0137891122538509 0.076058582
NSC 254665 JUSTICIDIN B 0.0137891122538509 0.17266777
NSC 321491 Null 0.0137891122538509 -0.29852592
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0137891122538509 0.36446656
NSC 643836 Null 0.0137891122538509 -0.22071838
NSC 647763 Jasplakinolide epoxide C 0.0137891122538509 0.41042167
NSC 666138 Null 0.0137891122538509 -0.14088125
Total:71  Current:30    [First] [Prev] [Next] [Last]